For startups, reaching unicorn status — a valuation at over $1 billion — is a major milestone. And with its latest funding round, Biofourmis just surpassed getting there. The company announced Tuesday that it has raised $300 million in Series D. The news runs counter to CB Insights’ recent findings that health tech funding, mega-round
The post Care-At-Home Startup Biofourmis Raises $300 Million in Funding, Surpasses Unicorn Status appeared first on Home Health Care News.

Read More